Prevalence of multidrug-, extensively drug-, and pandrug-resistant bacteria in clinical isolates from King Khaled Hospital, Najran, Saudi Arabia
Authors:
Open Access
- 12 November 2024
- journal article
- research article
- Published by Springer Nature in Discover Medicine
- Vol. 1 (1) , 1-14
Abstract
Background: Saudi Arabia faces a growing antimicrobial resistance (AMR) problem, exacerbated by the widespread use of antibiotics in clinical and agricultural settings. Despite this, AMR surveillance has been limited, particularly in regions like Najran, making this study critical for informing local and national public health strategies. Aim: This study explored the prevalence of multidrug-resistant, extensively drug-resistant, and Pandrug-resistant bacteria in Najran, Saudi Arabia. Study design: This is a cross-sectional study. Methods: This study included 559 diverse clinical samples (urine, wound, etc.) collected from various departments in King Khaled Hospital, Saudi Arabia. The Phoenix BD instrument was used for complete bacterial identification and antibiotic sensitivity testing. Demographic and clinical data were analyzed statistically. Results: Of the 559 samples, the culture positivity rates were as follows: 51% for Escherichia coli, 22% for Staphylococcus aureus, 14% for Klebsiella pneumoniae, 6% for Acinetobacter baumannii, 6% for Pseudomonas aeruginosa, and 1% for Enterococcus faecium. Majority of the cases were from male (57%), and age 50+ (59%) recorded highest cases. Participants from outpatient department (OPD) ward recorded the highest (56%) cases, while urine sample recorded the highest (49%) cases. About 84% of the isolates were multidrug‑resistance (MDR), 10% were extensively drug‑resistance (XDR), and 6% pandrug‑resistance (PDR). Our analysis showed high sensitivity to Oxazolidonone, Tetracycline, carbapenems, Lipopeptide, Aminoglycopeptide classes of antibiotics. Conclusions: The study revealed a high prevalence of drug resistance, highlighting the critical importance of continued surveillance and research to mitigate the spread of antimicrobial resistance and preserve the effectiveness of existing therapies.Keywords
This publication has 30 references indexed in Scilit:
- Antibiotic Resistance Profile, Multidrug-, Extensively drug-, and Pandrug-Resistant Bacterial Isolates: Hemagglutination and Hemolytic Activities against Human ErythrocytesProceedings of the National Academy of Sciences, India Section B: Biological Sciences, 2024
- Role of Livestock on Food Security in Saudi Arabia2024
- Risk factors in acquiring multidrug-resistant Klebsiella pneumoniae infections in a hospital setting in Saudi ArabiaScientific Reports, 2023
- Antimicrobial Resistance in Urinary Tract InfectionsCurrent Bladder Dysfunction Reports, 2023
- A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically Ill patients: Clinical and microbiological findingsJournal of Infection and Public Health, 2023
- Current Treatment Strategies Against Multidrug-Resistant Bacteria: A ReviewCurrent Microbiology, 2022
- Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologiesIntensive and Critical Care Nursing, 2022
- Methicillin and multidrug resistant pathogenic Staphylococcus aureus associated sepsis in hospitalized neonatal infections and antibiotic susceptibilityJournal of Infection and Public Health, 2021
- Impact of Difficult-to-Treat Resistance in Gram-negative Bacteremia on Mortality: Retrospective Analysis of Nationwide Surveillance DataClinical Infectious Diseases, 2020
- Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line AgentsClinical Infectious Diseases, 2018